Trial intelligence / Profile preview

Pharmacokinetics of Daptomycin in Critically Ill Patients on CVVHD

NCT00663403Phase 4Completed

Sponsor
University of Michigan
Start
Feb 2007
Primary completion
Apr 2009
Modality
Cyclic Peptides, Antimicrobial Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of daptomycin in bacterial infection, sponsored by University of Michigan. Started Feb 2007; status: completed.

02

Drugs

daptomycin
03

Conditions

bacterial infection

Beyond the preview

Go deeper on NCT00663403.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00663403.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call